
NVAX • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold NVAX in your mock portfolio yet.
Novavax shows positive earnings with an EPS of 2.01 and a very low PE ratio of 4.30, suggesting the stock is priced cheaply relative to current earnings. However, without visibility into revenue growth, margin stability, or sustainability of these earnings, the market’s discount implies skepticism about the durability and quality of profits. Overall, the financial snapshot looks optically attractive but is clouded by uncertainty about forward prospects.
The stock trades at $8.65, down 12.6% over the last month, indicating recent negative momentum. An RSI of 22.98 puts the shares in oversold territory, while the price sitting modestly above the 200-day moving average of $7.59 suggests longer-term trend support but near-term selling pressure. Technically, the setup reflects a weak tape with potential for short-term bounces, but the prevailing trend and sentiment remain negative.
Alternative data points suggest weakening or stagnant business and brand momentum. Web traffic at ~46k monthly visitors is modest, and the complete absence of job openings with a 100% month-over-month decline indicates no active expansion and potentially cost-cutting or retrenchment. Social media metrics are flat to slightly negative on Twitter/X and YouTube, with only a small uptick on LinkedIn, pointing to limited engagement growth and subdued external interest.
Overall, the setup for Novavax appears bearish despite superficially attractive valuation metrics. The combination of recent price weakness, oversold technicals, zero hiring, and flat-to-declining engagement signals suggests the market is discounting future growth and sustainability of current earnings. While oversold conditions could support short-term rebounds, the broader risk-reward profile skews negatively until there is clearer evidence of durable demand and operational momentum.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: